Overview

Evaluate Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD

Status:
Unknown status
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of ORADUR®-Methylphenidate in children and adolescents with ADHD.
Phase:
Phase 3
Details
Lead Sponsor:
Orient Pharma Co., Ltd.
Collaborator:
Durect
Treatments:
Methylphenidate